HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL.PK) today announced that all comments from the U.S. Securities and Exchange Commission’s review of the Company’s Form 10 Registration Statement have been resolved. Additionally, the Financial Industry Regulatory Authority (FINRA) has approved the application of several market makers to resume quotations of the Company’s common stock (symbol IPXL.PK) on the Pink Sheets.
